Celera Genomics Teams With GE To Develop Cancer Imaging Agents
This article was originally published in The Gray Sheet
Executive SummaryGE Global Research will assume responsibility for the regulation and manufacture of imaging agents to be jointly developed with Celera Genomics
You may also be interested in...
The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.